MENU
ENGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
enGene Holdings (ENGN) Ownership - Who owns enGene Holdings?
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients... Show more
Profile
Industry
N/A
Address
7171 Rue Frederick Banting
Phone
+1 514 332-4888
Employees
N/A
Web
N/A
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
203.4M
P/E Ratio
N/A
Total Cash
213.81M
Projected Growth
N/A
Total Debt
25.13M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
4.19
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ENGN
Capitalization
203M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
214M
Total Cash/Share
4.19
Total Debt
25.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
250M
P/B Ratio
0.81
Cash Flow
N/A
Earnings
-1.48
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
510M
Current Ratio
17.16
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-65.69M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-36.40
Shares Held By Institutions
293M
Shares Outstanding - Current
51M
Total Liabilities
36M
Total Volume MTD
N/A
Value
1
Gain YTD
-40.000
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
7171 Rue Frederick Banting
Phone
+1 514 332-4888
Employees
N/A
Web
N/A